Answers are grounded in this paper and cite their sources.
Limited knowledge exists regarding behavioral and biomarker shifts during the period from respiratory infection exposure to testing decisions (the diagnostic decision period), a key phase affecting transmission dynamics and public health strategy development. This study aims to examine the changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS).
No takes yet. Share an insight, caveat, or question.
Snir et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: